Synopsis:
In this symposia, presenters will review the latest evidence informing the use of Upadacitinib in rheumatologic conditions in the context of today’s treatment landscape and clinical practice.
Learnings from real world evidence and how this data can inform on key considerations for improving patient outcomes in clinical practice will also be discussed.
Agenda:
|
|
Chairperson: Prof. Kunihiro Yamaoka
|
|
11:10-11:15 |
Welcome Remarks: Introduction
|
|
11:15-11:35 |
New Horizons in the Treatment of GCA
Dr Ryu Watanabe |
|
11:35-12:00 |
Enhancing RA care: Unveiling Insights with current data
Dr Eduardo Mysler and Dr Ryu Watanabe |
|
12:10-12:15 |
Closing Remarks: Q&A and Discussion
All |
